Login
Patents
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
Briefing.com: Hourly In Play (R) - 20:00 ETCompetitive IntelligenceWed, January 31st - 12:00 AM 2018
SEC Filings: Form 424B3: Form of prospectus reflecting facts events constituting substantive change from last form 01/04/18Competitive IntelligenceWed, January 31st - 12:00 AM 2018
NDA for Novel Major Depressive Disorder Treatment Submitted to FDACompetitive IntelligenceWed, January 31st - 12:00 AM 2018
Alkermes Submits New Drug Application To U.S. FDA For ALKS 5461 For The Adjunctive Treatment Of Major Depressive DisorderCompetitive IntelligenceWed, January 31st - 12:00 AM 2018
SEC Filings: Form 424B5: Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3 01/29/18Competitive IntelligenceWed, January 31st - 12:00 AM 2018
Alkermes falls in 4 out of last 5 days January 31, 2018 16:00 ESTCompetitive IntelligenceWed, January 31st - 12:00 AM 2018
Swiss Official Gazette of Commerce notice: HR of Canton Zug: No. of SOGC 026 from 07.02.2018/Notice no 4041105/New entriesCompetitive IntelligenceThu, February 8th - 12:00 AM 2018
Change in the Board of DirectorsCompetitive IntelligenceThu, February 8th - 12:00 AM 2018
Newron Pharmaceuticals S.p.A. Announces Change in the Board of DirectorsCompetitive IntelligenceFri, February 9th - 12:00 AM 2018
Auris Medical Announces Extraordinary General Meeting of ShareholdersCompetitive IntelligenceFri, February 9th - 12:00 AM 2018